Human epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide

  • Catalog number
    AB-23036-P
  • Price
    Please ask
  • Size
    100ug
  • Stock availability
    Available
  • Category
    Primary Antibodies
  • Antibody type
    Polyclonal Antibody
  • Antibody host
    Rabbit
  • Antibody conjugate
    N/A
  • Technical datasheet
    Contact Gentaur to request the datasheet or ask our specialists for more information.
  • Notes
    The Human epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.
  • Test
    You can block the antibody by the specific target amino acid sequence of peptide.
  • Properties
    blocking peptide, Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
  • Description
    Isotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
  • Gene target
  • Gene symbol
    EPM2A, EPM2A-DT
  • Short name
    epilepsy, progressive myoclonus 2A (EPM2A) Control/blocking peptide
  • Technique
    blocking peptide, Blocking, Control, peptide, blocking peptides, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. controls, peptides
  • Species
    Human, Humans
  • Alternative name
    H. sapiens epilepsy, progressive myoclonus classification 2A (EPM2A) reference/inhibiting short protein sequence
  • Alternative technique
    control, peptides, controls
  • Tissue
    control
Gene info
  • Identity
  • Gene
  • Long gene name
    EPM2A glucan phosphatase, laforin
  • Synonyms gene name
    • epilepsy, progressive myoclonus type 2, Lafora disease (laforin)
    • epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
    • EPM2A, laforin glucan phosphatase
  • Synonyms
  • GenBank acession
  • Locus
  • Discovery year
    1998-10-01
  • Entrez gene record
  • Pubmed identfication
  • Classification
    • Atypical dual specificity phosphatases
  • VEGA ID
Gene info
  • Identity
  • Gene
  • Long gene name
    EPM2A divergent transcript
  • Synonyms gene
  • Synonyms gene name
    • FBXO30 divergent transcript
  • Locus
  • Discovery year
    2020-01-17
  • Entrez gene record
  • Pubmed identfication
  • RefSeq identity
  • Classification
    • Divergent transcripts
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee